Unlocking the potential: Baicalin's apoptosis-reducing power and activation of NRF2/P62 for alleviating diabetic cardiomyopathy in rats
ConclusionBaicalin may reduce the effects of DCM by activating NRF2 through KEAP1 suppression and regulating autophagy activation.
Source: Molecular and Cellular Toxicology - Category: Cytology Source Type: research
More News: Cardiology | Cardiomyopathy | Cytology | Diabetes | Endocrinology | Genetics | Heart | Study | Toxicology